InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
12
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Rodman David Malcom, Chief Medical Officer. Insider active across 1 company, notably Mineralys Therapeutics, Inc.. In total, 63 disclosures have been recorded. Split: 0 buy · 12 sells. Total volume traded: €2m. History available since 10 August 2023. The latest transaction was disclosed on 10 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Rodman David Malcom
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations63 total
2,170 shares@ US$16.000.0014% mcap0.8% of flowCommon StockSEC:0001933414-26-000118:0
2,170 shares@ US$27.090.0024% mcap1.4% of flowCommon StockSEC:0001933414-26-000118:1
416 shares@ US$26.530.0005% mcap0.3% of flowCommon StockSEC:0001672659-26-000036:1
416 shares@ US$15.440.0003% mcap0.2% of flowCommon StockSEC:0001672659-26-000036:0
14,058 shares@ US$27.57980.014% mcap9.2% of flowCommon StockSEC:0001933414-26-000099:3
6,349 shares@ US$26.61120.0059% mcap4.0% of flowCommon StockSEC:0001933414-26-000099:4
3,542 shares@ US$10.200.0013% mcap0.9% of flowCommon StockSEC:0001933414-26-000099:0
4,167 shares@ US$14.250.0021% mcap1.4% of flowCommon StockSEC:0001933414-26-000099:1
6,349 shares@ US$1.080.0002% mcap0.2% of flowCommon StockSEC:0001933414-26-000099:2
2,171 shares@ US$16.000.0014% mcap1.6% of flowCommon StockSEC:0001672659-26-000033:0
2,171 shares@ US$30.300.0028% mcap1.5% of flowCommon StockSEC:0001672659-26-000033:1
2,171 shares@ US$16.000.0013% mcap1.9% of flowCommon StockSEC:0001672659-26-000027:0
416 shares@ US$15.440.0002% mcap0.2% of flowCommon StockSEC:0001672659-26-000024:0
416 shares@ US$31.330.0005% mcap0.5% of flowCommon StockSEC:0001672659-26-000024:1
6,349 shares@ US$1.080.0003% mcap0.2% of flowCommon StockSEC:0001933414-26-000076:0
3,542 shares@ US$10.200.0014% mcap1.3% of flowCommon StockSEC:0001933414-26-000076:1
4,167 shares@ US$14.250.0022% mcap2.1% of flowCommon StockSEC:0001933414-26-000076:2
14,058 shares@ US$26.53910.014% mcap13.1% of flowCommon StockSEC:0001933414-26-000076:3
6,348 shares@ US$27.660.0066% mcap6.2% of flowCommon StockSEC:0001933414-26-000076:4
2,170 shares@ US$16.001.2% of flowCommon StockSEC:0001672659-26-000020:0
2,170 shares@ US$27.382.0% of flowCommon StockSEC:0001672659-26-000020:1
417 shares@ US$15.440.3% of flowCommon StockSEC:0001672659-26-000018:0
6,348 shares@ US$1.080.0003% mcap0.4% of flowCommon StockSEC:0001933414-26-000058:0
2,171 shares@ US$16.001.6% of flowCommon StockSEC:0001672659-26-000015:0
38,400 shares0Common StockSEC:0001933414-26-000038:0
25 of 63 declarations
About Rodman David Malcom
Rodman David Malcom is Chief Medical Officer at Mineralys Therapeutics, Inc. Across 54 filings in total, the 54 most recent filings we hold, covering the period from 2023-08-11 to 2026-07-10, show €0 of purchases and €1407365 of sales, with the transaction nature listed as option exercise.
